Your browser doesn't support javascript.
loading
Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP).
Balk, Matthias; Rupp, Robin; Mantsopoulos, Konstantin; Allner, Moritz; Grundtner, Philipp; Mueller, S K; Traxdorf, Maximilian; Eckstein, Markus; Speer, Stefan; Semrau, Sabine; Fietkau, Rainer; Iro, Heinrich; Hecht, Markus; Gostian, Antoniu-Oreste.
Affiliation
  • Balk M; Department of Otolaryngology, Head & Neck Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, 91054, Erlangen, Germany. matthias.balk@uk-erlangen.de.
  • Rupp R; Department of Otolaryngology, Head & Neck Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, 91054, Erlangen, Germany.
  • Mantsopoulos K; Department of Otolaryngology, Head & Neck Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, 91054, Erlangen, Germany.
  • Allner M; Department of Otolaryngology, Head & Neck Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, 91054, Erlangen, Germany.
  • Grundtner P; Department of Otolaryngology, Head & Neck Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, 91054, Erlangen, Germany.
  • Mueller SK; Department of Otolaryngology, Head & Neck Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, 91054, Erlangen, Germany.
  • Traxdorf M; Department of Otolaryngology, Head & Neck Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, 91054, Erlangen, Germany.
  • Eckstein M; Department of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Speer S; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Semrau S; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Fietkau R; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Iro H; Department of Otolaryngology, Head & Neck Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, 91054, Erlangen, Germany.
  • Hecht M; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Gostian AO; Department of Otolaryngology, Head & Neck Surgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, 91054, Erlangen, Germany.
BMC Cancer ; 21(1): 1236, 2021 Nov 18.
Article de En | MEDLINE | ID: mdl-34794411
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Évidement ganglionnaire cervical / Métastases d'origine inconnue / Chimioradiothérapie adjuvante / Carcinome épidermoïde de la tête et du cou / Tumeurs de la tête et du cou Type d'étude: Observational_studies Limites: Female / Humans / Male / Middle aged Langue: En Journal: BMC Cancer Sujet du journal: NEOPLASIAS Année: 2021 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Évidement ganglionnaire cervical / Métastases d'origine inconnue / Chimioradiothérapie adjuvante / Carcinome épidermoïde de la tête et du cou / Tumeurs de la tête et du cou Type d'étude: Observational_studies Limites: Female / Humans / Male / Middle aged Langue: En Journal: BMC Cancer Sujet du journal: NEOPLASIAS Année: 2021 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Royaume-Uni